September 9, 2016 - Curant Health COO, Marc O'Connor, in Managed Healthcare Executive - Healthcare technology simultaneously grinds away like a rusty squeezebox (i.e., EMRs & interoperability) and advances at breakneck speed in a constant attempt to support the industry sea-change born by the advent of value-based care.
Venture capital funding in healthcare information technology alone reached $1.4 billion in the first quarter of 2016, according to Mercom Capital Group.
Every day my colleagues and I at Curant Health evaluate new technologies purporting to improve medication adherence, particularly for chronically ill patients. Depending on study parameters, medication nonadherence represents between $100 million and $300 million in wasted healthcare spending every year. We are also big fans platforms which connect multiple members of a patient’s care team and provides them with data to improve outcomes.
Our own EMR, in which we have invested heavily, secures information critical to obtaining high rates of medication adherence and the associated improvements in value for clinicians, pharmaceutical manufacturers and payers.
The current limits of “smart everything”
Healthcare technology innovation and the Internet of Things has brought what seems like “smart everything” to healthcare. Many of these innovations are profound, life saving and value-based. However, there remains an easily identifiable limit to technology’s ability to impact factors that affect outcomes, such as medication adherence, at which point the only solution is a caring human hand or voice that seeks to understand why a patient is exhibiting non-adherence to costly medication therapies.
To read Marc’s full article, visit Managed Healthcare Executive.
To learn more about Curant Health, contact Kristin Lindsey, Senior Marketing Director, at klindsey@curanthealth.com.